Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBT: 2021-2025

Historic EBT for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$146.5 million.

  • Core Scientific's EBT rose 67.80% to -$146.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$767.4 million, marking a year-over-year increase of 38.33%. This contributed to the annual value of -$1.3 billion for FY2024, which is 434.63% down from last year.
  • Latest data reveals that Core Scientific reported EBT of -$146.5 million as of Q3 2025, which was up 84.36% from -$936.6 million recorded in Q2 2025.
  • Core Scientific's 5-year EBT high stood at $580.9 million for Q1 2025, and its period low was -$936.6 million during Q2 2025.
  • Over the past 3 years, Core Scientific's median EBT value was -$146.5 million (recorded in 2025), while the average stood at -$187.5 million.
  • As far as peak fluctuations go, Core Scientific's EBT crashed by 25,965.69% in 2022, and later soared by 74,359.51% in 2024.
  • Over the past 5 years, Core Scientific's EBT (Quarterly) stood at $77.0 million in 2021, then crashed by 692.91% to -$456.3 million in 2022, then spiked by 57.19% to -$195.4 million in 2023, then tumbled by 35.73% to -$265.2 million in 2024, then soared by 67.80% to -$146.5 million in 2025.
  • Its EBT was -$146.5 million in Q3 2025, compared to -$936.6 million in Q2 2025 and $580.9 million in Q1 2025.